New risk score tool aims to cut strokes in heart condition patients

NCT ID NCT03753490

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether using a personalized risk score (ABC-score) to guide treatment can lower the chance of stroke or death in people with atrial fibrillation, a common heart rhythm problem. About 3,900 participants are randomly assigned to either standard care or treatment based on their ABC-risk scores. The goal is to see if tailored recommendations for blood thinners and other therapies improve survival without major bleeding.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ABC score-guided therapy (personalized treatment recommendations based on biomarker-based risk scores)
What this could lead to
If successful, this could provide a more effective way to prevent strokes and deaths in people with atrial fibrillation by tailoring treatments to individual risk.
What could go wrong
This is a large trial but still early in testing a decision-support tool, not a drug. The approach may not significantly improve outcomes over standard care, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uppsala University Hospital

    Uppsala, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.